It is noteworthy that the dual CD47/PD‐L1 blockade treatment induced by free antibodies of CPA demonstrated a dose‐dependent synergistic enhanced effect in tumor growth inhibition due to the deficient tumor accumulation of systemic administration of free antibodies induced by the on‐target off‐tumor immunotoxicity. This evidence concerns the gene CD274 and neoplasm.